Company intelligence / Profile preview
Golgi Neurosciences
Milan, Lombardy, Italygolgineurosciences.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Golgi Neurosciences operates as a biotech incubator with a strong focus on small molecule drug discovery for neurodegenerative diseases. It has spun out or co-founded six biotech companies, several of which have advanced programs in clinical development. Its own proprietary pipeline is at the discovery/preclinical stage, with assets available for further development or partnering. Portfolio company Acousia Therapeutics has completed Phase 1b trials and is running Phase 2 studies; other portfolio firms are advancing toward the clinic in various CNS indications.
- Therapeutic areas
- OphthalmologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
International research centersCDD VaultNovo HoldingsSofinnova Partners
Beyond the preview
Go deeper on Golgi Neurosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Golgi Neurosciences.